-
Mashup Score: 0
New policy brief from World Obesity, analysing the global disparities in paediatric weight management.
Source: www.worldobesity.orgCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0
New policy brief from World Obesity, analysing the global disparities in paediatric weight management.
Source: www.worldobesity.orgCategories: Endocrinology, Latest HeadlinesTweet-
Paediatric treatment effectiveness may be affected by social disparities. Our policy brief highlights the importance for #CHO treatment interventions to be culturally/socially sensitive, avoid #stigma, encourage motivations & reinforce opportunities. ➡️ https://t.co/1NpsL0xTdK https://t.co/FXUqUPqYLD
-
-
Mashup Score: 0
New policy brief from World Obesity, analysing the global disparities in paediatric weight management.
Source: www.worldobesity.orgCategories: Endocrinology, Latest HeadlinesTweet-
Paediatric treatment effectiveness may be affected by social disparities. Our policy brief highlights the importance for #CHO treatment interventions to be culturally/socially sensitive, avoid #stigma, encourage motivations & reinforce opportunities. ➡️ https://t.co/1NpsL0xTdK https://t.co/5PYy1Rt1XG
-
-
Mashup Score: 4
New policy brief from World Obesity, analysing the global disparities in paediatric weight management.
Source: www.worldobesity.orgCategories: Endocrinology, Latest HeadlinesTweet-
Paediatric treatment effectiveness may be affected by social disparities. Our policy brief highlights the importance for #CHO treatment interventions to be culturally/socially sensitive, avoid #stigma, encourage motivations & reinforce opportunities. ➡️ https://t.co/1NpsL0xTdK https://t.co/CCmgWnX0L1
-
-
Mashup Score: 0Online Event - 1 year(s) ago
Already Registered? Click HereSince the first approval of a recombinant biopharmaceutical in 1986, Chinese hamster ovary (CHO) cells have become the industry workhorse for biologics production. While there have been dramatic improvements in multiple areas of cell line development (e.g., transfection and fed-batch process), the design of the vector still typically relies on a “one-size-fits-all…
Source: www.workcast.comCategories: Future of Medicine, Latest HeadlinesTweet-
ONE HOUR FROM NOW, Join our free webinar sponsored by @AsimovBio In this GEN webinar, we will hear about a new #CHO platform that moves beyond the one-size-fits-all paradigm by tailoring vectors for each molecule to optimize expression. Register now: https://t.co/0UCKxParqU https://t.co/LFoKhAlNHV
-
-
Mashup Score: 1Online Event - 1 year(s) ago
Already Registered? Click HereSince the first approval of a recombinant biopharmaceutical in 1986, Chinese hamster ovary (CHO) cells have become the industry workhorse for biologics production. While there have been dramatic improvements in multiple areas of cell line development (e.g., transfection and fed-batch process), the design of the vector still typically relies on a “one-size-fits-all…
Source: www.workcast.comCategories: Future of Medicine, Latest HeadlinesTweet-
Join us LATER TODAY at 11 am ET for our free webinar! In this GEN webinar, we will hear about a new #CHO platform that moves beyond the one-size-fits-all paradigm by tailoring vectors for each molecule to optimize expression. Register now: https://t.co/0UCKxPaZgs https://t.co/26hvaIQQwh
-
-
Mashup Score: 4Online Event - 1 year(s) ago
Already Registered? Click HereSince the first approval of a recombinant biopharmaceutical in 1986, Chinese hamster ovary (CHO) cells have become the industry workhorse for biologics production. While there have been dramatic improvements in multiple areas of cell line development (e.g., transfection and fed-batch process), the design of the vector still typically relies on a “one-size-fits-all…
Source: www.workcast.comCategories: Future of Medicine, Latest HeadlinesTweet-
Join us TOMORROW at 11 am ET for our free webinar! In this GEN webinar, we will hear about a new #CHO platform that moves beyond the one-size-fits-all paradigm by tailoring vectors for each molecule to optimize expression. Register now: https://t.co/0UCKxParqU https://t.co/JCZGGcwUN2
-
-
Mashup Score: 0
New policy brief from World Obesity, delivering a message to the World Health Assembly.
Source: World Obesity FederationCategories: Endocrinology, Latest HeadlinesTweet-
With #COVID19, it is essential to maintain momentum on #CHO and ensure policies to promote child health are included in efforts to #BuildBackBetter. Our brief identifies points of intersection between #COVID19 & #CHO prevention and management. ➡️ https://t.co/kVvoCtMSzS https://t.co/g07sVO00Cw
-
-
Mashup Score: 0
New policy brief from World Obesity, delivering a message to the World Health Assembly.
Source: World Obesity FederationCategories: Endocrinology, Latest HeadlinesTweet-
With #COVID19, it is essential to maintain momentum on #CHO and ensure policies to promote child health are included in efforts to #BuildBackBetter. Our brief identifies points of intersection between #COVID19 & #CHO prevention and management. ➡️ https://t.co/kVvoCtMSzS https://t.co/2QUEYndk8f
-
-
Mashup Score: 0
New policy brief from World Obesity, delivering a message to the World Health Assembly.
Source: World Obesity FederationCategories: Endocrinology, Latest HeadlinesTweet-
With #COVID19, it is essential to maintain momentum on #CHO and ensure policies to promote child health are included in efforts to #BuildBackBetter. Our brief identifies points of intersection between #COVID19 & #CHO prevention and management. ➡️ https://t.co/kVvoCtMSzS https://t.co/L2ZKnQLnJL
-
Paediatric treatment effectiveness may be affected by social disparities. Our policy brief highlights the importance for #CHO treatment interventions to be culturally/socially sensitive, avoid #stigma, encourage motivations & reinforce opportunities. ➡️ https://t.co/1NpsL0xTdK https://t.co/20hnjyoK1b